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Summary Heparan sulphate-associated anionic sites 
in the glomerular basement membrane were studied 
in rats 8 months after induction of diabetes by strep- 
tozotocin and in age- and sex-matched control rats, 
employing the cationic dye cuprolinic blue. Morpho- 
metric analysis at the ultrastructural level was per- 
formed using a computerized image processor. The 
heparan sulphate specificity of the cuprolinic blue 
staining was demonstrated by glycosaminoglycan-de- 
grading enzymes, showing that pretreatment of the 
sections with heparitinase abolished all staining, 
whereas chondroitinase ABC had no effect. The ma- 
jority of anionic sites (74 % in diabetic and 81% in 
control rats) were found within the lamina rara ex- 
terna of the glomerular basement membrane. A mi- 
nority of anionic sites were scattered throughout the 
lamina densa and lamina rara interna, and were sig- 
nificantly smaller than those in the lamina rara 
externa of the glomerular basement membrane 
(p < 0.001 and p < 0.01 for diabetic and control rats, 
respectively). Diabetic rats progressively developed 
albuminuria reaching 40.3 (32.2-62.0)mg/24 h after 
8 months in contrast o the control animals (0.8 (0.2- 
0.9) mg/24 h, p < 0.002). At the same time, the num- 
ber of heparan sulphate anionic sites and the total an- 
ionic site surface (number of anionic sites x mean an- 
ionic site surface) in the lamina rara externa of the 
glomerular basement membrane was reduced by 
19 % (p < 0:021) and by 26 % (p < 0.02), respectively. 
Number and total anionic site surface in the remain- 
ing part of the glomerular basement membrane 
(lamina densa and lamina rara interna) were not sig- 
nificantly changed. We conclude that in streptozoto- 
cin-diabetic rats with an increased urinary albumin 
excretion, a reduced heparan sulphate charge bar- 
rier/density is found at the lamina rara externa of the 
glomerular basement membrane. [Diabetologia 
(1995) 38: 1169-1175] 
Key words Albuminuria, anionic sites, cuprolinic 
blue, glomerular basement membrane, heparan sul- 
phate, rat, streptozotocin. 
Heparan sulphate (HS) is thought o play an impor- 
tant role in the permselective properties of the glom- 
erular capillary wall [1-3], since enzymatic digestion 
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of HS in the glomerular basement membrane 
(GBM) causes an increased passage of native ferritin 
and albumin into the urinary space [4, 5]. Further- 
more, intrarenal or intravenous injection of cationic 
molecules leads to an increased permeability of the 
GBM to proteins, due to the neutralization of primar- 
ily HS-associated anionic sites of the glomerular cap- 
illary wall [6-8]. We have recently demonstrated the 
induction of an acute selective proteinuria fter intra- 
venous injection of a monoclonal antibody against 
GBM HS [91. 
Diabetic nephropathy ultimately develops in 30- 
40 % of patients uffering from insulin-dependent di-
abetes mellitus and is initially characterized by micro- 
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albuminuria [10, 11]. The selectivity index of the pro- 
teinuria in diabetic patients with microalbuminuria 
[12-15] suggested a decreased charge-dependent per- 
meabil i ty of the GBM. For that reason the signifi- 
cance of GBM heparan sulphate proteoglycan 
(HSPG)  for the development  of albuminuria in dia- 
betic nephropathy has been analysed in several stud- 
ies by quantitat ion of HSPG or HS in glomeruli  or 
isolated GBM.  Studies in humans revealed a de- 
creased content of HS and HSPG within the GBM 
of kidneys from IDDM patients [16-18]. Investiga- 
tions have also been per formed in exper imental  mod- 
els of diabetic nephropathy, mostly in the streptozo- 
tocin (STZ)- induced iabetes model  in the rat: Bio- 
chemical quantitat ion of HS in the GBM,  in glomer- 
uli or in the renal cortex revealed a decreased [19- 
22] or unaltered [23, 24] HS content in rats with 
STZ- induced diabetic nephropathy. However,  these 
studies do not discriminate between HSPG present 
in the peripheral  GBM,  or in the enlarged mesangial 
matrix that also contains HSPG. An  alternative ap- 
proach is to visualize HS and/or HSPG-core  protein 
by immunohistochemical  nd histochemical meth- 
ods. We found, using monoclonal  antibodies, a de- 
creased staining for HS in the GBM in k idney biop- 
sies f rom diabetic patients, which correlated with the 
fractional protein excretion, whereas the GBM stain- 
ing for the core protein of HSPG was unaltered [25, 
26]. Others, however,  found a decreased GBM stain- 
ing for the core protein of HSPG in diabetic kidneys 
[27, 28]. Negatively charged molecules like HS can 
also be visualized by cationic dyes. For staining of 
HS, cuprolinic blue is very useful. Under  critical elec- 
trolyte concentrat ion this cationic dye specifically 
stains HS and can therefore be used as a marker  for 
GBM HS [29]. A recent study using cuprolinic blue 
demonstrated a reduct ion of HS-associated anionic 
sites within the GBM in patients with diabetic neph- 
ropathy, which was inversely correlated with the de- 
gree of albuminuria [30]. A decrease of the number  
and density of cuprolinic blue anionic sites in the 
GBM of diabetic BB-rats has also been demon- 
strated [31]. In this study we analysed the HS-associ- 
ated anionic sites in the GBM of STZ-diabetic rats 
with a pronounced albuminuria. 
Materials and methods 
Animals. Diabetes was induced in overnight-fasted male Wi- 
star-Mtinich rats (Jackson Laboratory, Bar Harbor, Me., 
USA) of 150 g body weight by intravenous injection of 55 mg 
STZ/kg body weight, freshly prepared in 10 mmol/1 citrate buf- 
fer (pH 4.5), 25 mg/ml. Animals were treated three times a 
week (Monday, Wednesday, Friday at 17.00 hours) with a low 
dose (1.2 IU) of bovine insulin (Ultralente, Novo, Copenha- 
gen, Denmark) to maintain blood glucose levels around 
25 mmol/1. Sex- and age-matched rats that did not receive 
STZ served as controls. The rats were followed-up monthly 
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for body weight, blood glucose and albuminuria s described 
previously [32]. Blood glucose level was determined by Hae- 
mo-Glukotest 1-44R (Boehringer Mannhein, Mannheim, Ger- 
many) and albuminuria by rocket electrophoresis according to 
Laurell [33] using goat anti-rat albumin and rat albumin as the 
standard (both from Nordic, Tilburg, The Netherlands). 
Tissue collection and cuprolinic blue staining. Eight months af- 
ter induction of diabetes, rats were anaesthetized by Inactin 
(Byk Gulden, Konstanz, Germany); control rats, 140 mg/kg 
body weight; diabetic rats, 110 mg/kg body weight; kidneys 
were removed, decapsulated and weighed. Small cubes 
(1 mm 3) of renal cortex tissue were fixed for 2 h by immersion 
fixation in lysine - periodate - 2 % paraformaldehyde fixa- 
tive, cryoprotected in 2.3 tool/1 sucrose for 1 h, snap-frozen 
and stored in liquid nitrogen. To avoid penetration problems 
of the cationic dye, 30-~tm cryostat sections were cut, rinsed 
for 10 min in 0.05 tool/1 sodium acetate buffer (pH 5.6), and 
stained overnight at room temperature in 0.05 sodium acetate 
buffer (pH 5.6) containing 2 % glutaraldehyde, 0.2 tool/1 
MgC12 and 0.2 % cuprolinic blue (BDH Chemicals, Poole, Dor- 
set, UK). Sections were rinsed three times for 10 min in the 
same buffer without cuprolinic blue, incubated for i h in a 
1% sodium tungstate solution followed by an additional 
30 rain in 1% sodium tungstate in 50 % ethanol, dehydrated 
in graded ethanol and embedded in Epon 812. Ultrathin sec- 
tions were prepared on a LKB Ultratome, poststained for 
45 rain with uranyl acetate and examined in a JEOL 1200 
EX II electron microscope (Jeol, Tokyo, Japan). Specificity of 
the cuprolinic blue staining for HS was controlled in two dia- 
betic and two control rats by a 1-h preincubation (before cup- 
rolinic blue staining) at 37 ~ of 30-~m cryostat sections with 
1 U/ml heparitinase from Flavobacterium heparinum (Sei- 
kagaku, Tokyo, Japan) in 0.1 tool/1 sodium acetate buffer con- 
taining 10 mmol/1 Ca ++ (pH 7.0), or with 0.1 U/ml chondroitin- 
ase ABC from Proteus vulgaris (Seikagaku) in 0.1 moll1 Tris/ 
HC1 (pH 8.0), or the buffers alone without he enzymes. 
Morphometric analysis. Thirty-five photomicrographs of ran- 
domly-chosen cross-sectioned glomerular capillary loops with 
a final magnification of 68,000 x were taken from at least 
three randomly-chosen glomeruli per animal. The photomicro- 
graphs were analysed using a CCD RGB camera (Sony CA- 
325 AP) with a macro objective, attached to a VIDASPlUs im- 
age analysis system (Kontron Inc., Mtinchen, Germany). Af- 
ter the image Was digitized, three lines were drawn interac- 
tively: the GBM was lined between the epithelial foot pro- 
cesses and the outer GBM and between the endothelial cells 
and the inner GBM. A third line was drawn just beneath the 
anionic sites in the lamina rara externa (LRE) of the GBM. 
The image was corrected for unequal lighting and background 
staining. A fixed threshold was applied to determine areas of 
positive staining. Since we observed that the anionic sites in 
the LRE were larger in size than those found in the remaining 
part of the GBM (lamina densa and lamina rata interna 
(LD + LRI) ), anionic site analysis was performed separately 
for the LRE and LD + LRI. From the resulting binary images 
of each photomicrograph the following parameters were calcu- 
lated: a) the number of anionic sites per ~tm GBM; b) the mean 
anionic site surface (nm2), which gives an impression of the 
mean surface (= area) of each individual anionic site; c) the to- 
tal anionic site surface (nm2/~tm GBM), defined as the number 
of anionic sites/~tm GBM multiplied with the mean anionic site 
surface (a x b); d) the thickness of the LRE and LD + LRI 
(nm); and e) the relative anionic site surface (%). Latter pa- 
rameter was calculated as follows: [ (total anionic site surface 
LRE or LD + LRI/total surface LRE or LD + LRI) x 100 %], 
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Fig. 1 (A-F). Staining of the HS-associated anionic sites in the 
GBM of a control (A,C,E) and a diabetic (B,D,F) rat. Note 
that the majority of the anionic sites are localized in the LRE 
of the GBM. The original photomicrographs are seen in (A) 
and (B). These images were digitized, three lines were drawn 
interactively as indicated in Methods, and the computerized 
anionic sites are shown in white (C) and (D). The correspond- 
ing binary images, on which the analysis was performed, are 
shown in (E) and (F). (Magnification: 50,000 x) 
and expresses the percentage of the LRE or LD + LRI which 
is occupied by anionic sites. The analysis of the GBM anionic 
sites after pretreatment with glycosaminoglycan-degrading en- 
zymes was also done on 35 photomicrographs from at least 
three randomly-chosen glomeruli/animal. 
Statistical analysis 
For statistical analysis the Mann-Whitney test was used for al- 
buminuria, blood glucose concentration, body weight and kid- 
ney weight (Table 1). To analyse the morphometric data we 
used a special analysis of variance (ANOVA) approach, name- 
ly a single-factor nested esign with random nesting factor, the 
single factor being presence/absence of diabetes, and animals 
as the nesting factor, p-values less than 0.05 were regarded as 
significant. Values are expressed as median values and (range). 
Results 
Development ofdiabetic nephropathy in STZ-diabetic 
rats. After a diabetes duration of 8 months an in- 
creased urinary albumin excretion developed and en- 
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Table 1. Characteristics of the rats 8 months after induction of diabetes 
Parameter Diabetic rats Control rats p-value 
(n = 8) (n = 5) Mann-Whitney 
Albuminuria (mg/24 h) 40.3 (32.2-62.0) 0.8 (0.2-0.9) < 0.002 
Blood glucose (mmol/1) 23.0 (20.9-25.2) 4.8 (4.5-5.1) < 0.002 
Body weight (g) 228 (212-256) 370 (368-391) < 0.002 
Wet kidney weight (g) 3.12 (2.96-3.26) 2.34 (2.25-2.51) < 0.002 
Values are median (range) 
Table 2. Influence of glycosaminoglycan-degrading enzymes on the number of anionic sites in the LRE or LD + LRI 
Rat no. No pretreatment Heparitinase Chondroitinase ABC 
LRE LD + LRI LRE LD + LRI LRE LD + LRI 
Diabetic 
1 36 12 3 3 34 9 
2 32 9 3 2 37 10 
Control 
1 37 8 2 1 34 6 
2 40 11 4 2 35 8 
Table 3. Analysis of the HS-associated anionic sites of the GBM 
Parameter Diabetic rats Control rats p-value 
(n = 8) (n = 5) ANOVA 
Lamina rara externa (LRE) 
Number of anionic sites (sites/~tm GBM) 
Surface/anionic s te (nm 2) 
Total anionic site surface (nm2/~tm GBM) 
Thickness LRE (nm) 
Relative anionic site surface (%) 
Lamina densa and lamina rata interna (LD + LRI)  
Number of anionic sites (sites%tm GBM) 
Surface/anionic s te (nm 2) 
Total anionic site surface (nm2/~tm GBM) 
Thickness LD + LRI (nm) 
Relative anionic site surface (%) 
34 (25-42) 42 (39-46) < 0.02 
150 (119-168) 163 (139-220) NS 
4957 (2975-7056) 6670 (5838-8580) < 0.02 
76 (63-88) 74 (72-86) NS 
6.79 (4.64-8.82) 9.31 (7.48-12.15) < 0.03 
12 (3-18) 10 (9-14) NS 
66 (57-82) a 62 (60-79) b NS 
895 (195-1148) 711 (600-936) NS 
208 (166-242) 162 (144-186) < 0.01 
0.45 (0.14-0.64) 0.44 (0.37~3.53) NS 
Values are median (range) 
a LD • LRI vs LRE, p < 0.001; b LD + LRI vs LRE, p < 0.01 
largement of the kidneys, which are both characteris- 
tic for diabetic nephropathy (Table 1). The diabetic 
animals were hyperglycaemic during =the ntire study 
period as controlled by monthly blood glucose moni- 
toring. The blood glucose values in Table 1 corre- 
spond to the blood glucose levels measured just be- 
fore the animals were killed. Table 1 also shows that 
the diabetic rats gained less weight compared to con- 
trol rats. Light microscopy demonstrated a moderate 
increase of the mesangial matrix in the glomeruli of 
most diabetic rats as described previously [32]. 
Analysis of  the HS-associated anionic sites in the 
GBM. The cuprolinic blue staining procedure yiel- 
ded a homogeneously-stained thin layer of anionic 
sites within the LRE of the GBM. These sites repre- 
sent, in the diabetic rats, 74 % and in the control rats, 
81% of the total number of anionic sites within the 
GBM. The other anionic sites were scattered 
throughout the LD + LRI (Fig. 1 A, B). Figure 1 also 
demonstrates the three lines which indicate the epi- 
thelial and endothelial borders of the GBM and 
which mark the layer of anionic sites in the LRE 
(Fig.IC, D). The corresponding binary images are 
shown in Figure i (E,F). The HS-specificity of the 
staining was demonstrated by pretreatment of sec- 
tions originating from two diabetic and two control 
rats with glycosaminoglycan-degrading enzymes. As 
can be seen in Table 2, pretreatment of the sections 
with heparitinase (an enzyme that specifically 
cleaves HS) reduced the number of anionic sites in 
the LRE and LD + LRI to background levels, 
whereas chondroitinase ABC (an enzyme that specif- 
ically cleaves chondroitin sulphate A and C and der- 
matan sulphate) had hardly any effect on the num- 
ber of anionic sites in the LRE and LD + LRI. Prein- 
cubation of the sections with acetate or. Tris buffer 
alone (control buffers for the glycosaminoglycan-de- 
grading enzymes) had no influence on the number of 
anionic sites in both LRE and LD +LRI  (not 
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shown). This indicates that in both the diabetic and 
control rats the GBM anionic sites are HS-associated. 
The results of the analysis of the anionic sites are 
shown in Table 3. The number of anionic sites in the 
LRE was significantly reduced in the diabetic rats by 
19 % compared to the control animals (p < 0.02). 
Since it has been suggested that the size of the an- 
ionic sites gives information about the proteoglycan 
structure [29], we also measured the mean anionic 
site surface in every individual rat. Although the 
mean anionic site surface in the LRE was not signifi- 
cantly different between both groups, there was a ten- 
dency towards smaller sites in the diabetic rats. The 
total anionic site surface in the LRE was reduced by 
26 % (p < 0.02), the relative anionic site surface in 
the LRE was significantly decreased in the diabetic 
rats by 27 % compared to control rats (p < 0.03), 
which was not due to a difference in the thickness of 
the LRE. These data suggest a reduced HS-associ- 
ated charge barrier within the LRE in the diabetic 
rats. A minority of anionic sites were found in the 
LD + LRI in both diabetic and control rats. Latter 
sites were significantly smaller than the anionic sites 
in the LRE (p < 0.001 for diabetic rats and p < 0.01 
for control rats). Consequently, lower values com- 
pared to the LRE were found for both the total and 
relative anionic site surface (Table 3). From these 
data it can be calculated that 15 or 10 % of the total 
anionic site surface in the GBM is located in the 
LD + LRI for the diabetic or control rats, respec- 
tively. This suggests, using this technique, that the 
HS-associated anionic sites in the LRE are the major 
determinants for GBM charge. 
Since all diabetic animals were only analysed 
8 months after diabetes induction, we did not find a 
correlation between the different anionic site param- 
eters and albuminuria. This is probably due to the 
fact that the analysis was done only at one time point 
(8 months) and not also at earlier time points. 
Discussion 
In this study the HS-associated anionic sites in the 
GBM of albuminuric STZ-diabetic rats and control 
rats were analysed using the cationic dye cuprolinic 
blue. It has been documented that under critical elec- 
trolyte conditions, this dye specifically stains HS in 
extracellular matrix [29], as also revealed by our con- 
trol experiments with diabetic and control animals 
using glycosaminoglycan-degrading enzymes. 
We found in this STZ-induced iabetic nephropa- 
thy model and in normal rats that the majority of the 
HS-associated anionic sites are localized in the LRE 
of the GBM. This was also found by Vernier et al. 
[30] in the kidneys of insulin-dependen t diabetic pati- 
ents and by Chakrabarti et al [31] in the kidneys of di- 
abetic BB-rats. The results show that in the LRE of 
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diabetic rats the number of anionic sites, the total an- 
ionic site surface and the relative anionic site surface 
were significantly decreased compared to control 
rats. These differences cannot be explained by differ- 
ences in the LRE width, since these were equal in 
both groups. These results trongly suggest a reduced 
HS-associated charge barrier within the LRE in ex- 
perimental diabetic nephropathy. No alterations 
were observed for the anionic sites in the LD + LRI 
of the GBM. The number of anionic sites in the 
LD + LRI represents 26 and 19 % of the total num- 
ber of anionic sites in the GBM for diabetic and con- 
trol rats, respectively. Furthermore, the mean surface 
per anionic site in the LD + LRI is significantly smal- 
ler than in the LRE. Since it has been suggested that 
the size of the anionic sites gives some information 
about the structure of the HSPG molecule [29], this 
analysis uggests that two types of GBM HS are pre- 
sent. The major population is identified as larger an- 
ionic sites in the LRE which are subject to altera- 
tions in diabetes, and a minor population, recognized 
as smaller anionic sites in the LD + LRI, which re- 
main unaltered in diabetes. In a previous tudy [34], 
we suggested the existence of at least two different 
types of basement membrane HSPG, based on differ- 
ences in glomerular staining pattern. Using a mono- 
clonal antibody against he core protein of the large 
EHS-HSPG we observed strong mesangial and weak 
GBM staining, whereas monoclonal antibodies 
against the core protein of GBM HSPG yielded 
weak mesangial and strong GBM staining. Whether 
these two different HSPG populations are related to 
the two different HS populations as found in the pre- 
sent study is not known. Furthermore, no data are 
available whether the expression of these two differ- 
ent types of HSPG in diabetes are regulated sepa- 
rately and differently. At the same time, one should 
realize that histological processing can markedly in- 
fluence the localization of HS-associated anionic 
sites in basement membranes, as shown by Chan et 
al. [35]. By changing the fixative from glutaralde- 
hyde to formaldehyde the cuprolinic blue HS-associ- 
ated anionic sites and the HSPG-core protein (visu- 
alized by the immunogold technique) were found to 
co-localize over the LD of basement membranes. 
This observation later led to the suggestion that the 
lamina lucidae/rarae of basement membranes were 
artefacts, and that HSPG is localized throughout the 
whole GBM [36]. This might indicate that the local- 
ization of HS-associated anionic sites in the LRE is 
due to redistribution during histological processing. 
Even if this is true, the total anionic site surface of 
all GBM anionic sites (LRE + LD + LRI) still de- 
creased by 21% (p < 0.02) and the relative anionic 
site surface of all GBM anionic sites decreased even 
by26 % as a consequence of the increased thickness 
of the GBM (p < 0.002). Therefore, irrespective of 
eventual redistribution of the HS-associated anionic 
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sites due to histological processing, our results indi- 
cate a reduced HS-associated charge barrier in the 
GBM of long-term diabetic rats, that might be ex- 
plained by a reduced number of HSPG molecules in 
the GBM and/or an altered structure; e.g., reduced 
charge of HS. 
In a previous study on isolated glomeruli of dia- 
betic rats 8 months after STZ injection, no absolute 
difference in GBM HS content was found between 
diabetic and control rats [32]. The HS measurements 
of that study were done on glomerular extracts with 
an inhibition-ELISA, using anti-HS monoclonal anti- 
body JM-403, specific for GBM HS [9]. Combining 
the results of the present study with those of the 
study mentioned above supports the idea of altera- 
tions in the structure of GBM HS. The most likely ex- 
planation for this is a reduction of the sulphation of 
GBM HS in diabetic rats. Undersulphation of HS 
both from the GBM [24] as well as from other tissues 
[37, 38] in STZ rats has been reported. Recently, it 
has been shown that culture of mesangial cells on 
non-enzymatic glycated mesangial matrix or pro- 
longed exposure to elevated glucose levels leads to 
the production of undersulphated proteoglycans [39, 
40]. HS sulphation occurs in the Golgi-apparatus of 
the producing cell and is determined by the key en- 
zyme glucosaminyl N-deacetylase [41]. A decreased 
activity of this enzyme has been found in STZ-dia- 
betic rats [42-44]. Finally, at present the influence of 
other diabetes-related factors such as non-enzymatic 
glycation on the staining properties of cuprolinic 
blue in diabetic GBM is not known. Non-enzymatic 
glycation of intrinsic GBM constituents and the 
cross-linking of non-enzymatic glycated serum pro- 
teins to the GBM leads to an altered three-dimen- 
sional architecture of the GBM [18, 45], that might in- 
terfere with the staining of the HS-associated anionic 
sites. In conclusion, this study demonstrates a re- 
duced HS charge barrier in the LRE of the GBM of 
rats with STZ-induced diabetes, which might explain 
the increased urinary albumin excretion found in 
these animals. 
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